BlackRock
GTBP icon

BlackRock’s GT Biopharma GTBP Stock Holding History

BlackRock’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07K Sell
332
-4
-1% -$41 ﹤0.01% 5505
2026
Q1 		$3.43K Hold
336
– – ﹤0.01% 5484
2025
Q4 		$6.6K Sell
336
-53
-14% -$941 ﹤0.01% 5321
2025
Q3 		$5.71K Hold
389
– – ﹤0.01% 5258
2025
Q2 		$34.9K Hold
389
– – ﹤0.01% 5057
2025
Q1 		$20.9K Hold
389
– – ﹤0.01% 5083
2024
Q4 		$29.7K Hold
389
– – ﹤0.01% 5046
2024
Q3 		$22.5K Sell
389
-2
-0.5% -$119 ﹤0.01% 4924
2024
Q2 		$27.6K Sell
391
-14
-3% -$1.25K ﹤0.01% 4959
2024
Q1 		$44.9K Hold
405
– – ﹤0.01% 4894
2023
Q4 		$77.5K Hold
405
– – ﹤0.01% 4875
2023
Q3 		$73.3K Sell
405
-1
-0.2% -$207 ﹤0.01% 4922
2023
Q2 		$95.1K Sell
406
-94
-19% -$24.4K ﹤0.01% 4932
2023
Q1 		$206K Buy
500
+3
+0.6% +$1.72K ﹤0.01% 4760
2022
Q4 		$330K Buy
497
+1
+0.2% +$1.25K ﹤0.01% 4716
2022
Q3 		$654K Sell
496
-6
-1% -$11.5K ﹤0.01% 4637
2022
Q2 		$1.13M Sell
502
-1,033
-67% -$1.96M ﹤0.01% 4491
2022
Q1 		$3.31M Sell
1,535
-20
-1% -$44.1K ﹤0.01% 4172
2021
Q4 		$3.56M Buy
1,555
+15
+1% +$56.1K ﹤0.01% 4143
2021
Q3 		$7.79M Sell
1,540
-345
-18% -$2.6M ﹤0.01% 3790
2021
Q2 		$21.9M Buy
+1,885
New +$19.6M ﹤0.01% 3241

Other funds holding GTBP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
A
Alongside Austin, Texas $525M AUM

BlackRock's GTBP Position: Q2 2026 in Review

BlackRock reduced its GT Biopharma (GTBP) stake by 1.2% in Q2 2026, selling an estimated $41 and leaving 332 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #5505.

BlackRock first reported a position in GTBP in Q2 2021 and has held it in 21 quarters since. The position peaked at $21.9M in Q2 2021. 55 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • BlackRock held 332 shares of GT Biopharma worth $4.07K as of Q2 2026.
  • BlackRock sold 4 GT Biopharma shares in Q2 2026, an estimated $41.
  • GT Biopharma made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5505 holding.
  • BlackRock first reported a position in GT Biopharma in Q2 2021 and has held it in 21 quarters since.
  • BlackRock's GT Biopharma position peaked at $21.9M in Q2 2021.
  • 55 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.